Delivery Order SPE2DB22D3011-SPE2DB25FQ2BH
Award Date 7/31/25
Potential Completion Date 8/21/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,241.54 delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a direct procurement of pharmaceutical supplies for federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,881.36 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/ml syringes, with an ultimate completion date of August 25, 2025. This competitive award, issued on August 4, 2025, utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,644.08 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $21,610.20 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes on August 13, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract fulfilling pharmaceutical supply requirements for federal medical procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,440.70 for XOLAIR 150 mg/mL syringes under a firm fixed price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 26, 2025. This delivery order represents a non-competitive, non-set-aside procurement and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, valued at $2,161.02, with an ultimate completion date of August 21, 2025. This is a firm fixed price, non-set-aside delivery order issued on July 31, 2025, under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,644.16 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,440.70 for XOLAIR 150 mg/mL syringes, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $2,881.36 delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes, with an ultimate completion date of August 13, 2025. This firm fixed price contract, awarded July 23, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $25,932.24 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...